Tender Description
Notice type: Justification · NAICS 611430 · PSC U004 On September 21, 2023, the U.S. Food and Drug Administration (FDA) awarded Purchase Order No. 75F40123P00426 to BIOMEDICAL RESEARCH ALLIANCE OF NEW YORK LLC (UEI: L1K7UFDEG5N5) on a sole-source basis in accordance with the procedures of FAR Subpart 13.5- Simplified Procedures for Certain Commercial Products and Commercial Services. In accordance with FAR 13.501(a)(1)(iii) and FAR 6.305, the FDA is making publically available the sole-source justification and approval for this acquisition of web-based training services.
- Country
- United States
- Published
- 21 Sept 2023
- Closing date
- 21 Oct 2023
- Procedure
- Justification